Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the recipient of a significant growth in short interest in August. As of August 31st, there was short interest totaling 756 shares, a growth of 3,878.9% from the August 15th total of 19 shares. Based on an average daily volume of 3,423 shares, the short-interest ratio is currently 0.2 days.
Carl Zeiss Meditec Stock Performance
Carl Zeiss Meditec stock traded up $0.19 during midday trading on Thursday, reaching $35.85. 1,132 shares of the stock were exchanged, compared to its average volume of 4,242. Carl Zeiss Meditec has a 52 week low of $26.65 and a 52 week high of $55.94. The company’s fifty day moving average is $34.91 and its 200-day moving average is $31.68.
Analyst Upgrades and Downgrades
CZMWY has been the subject of a number of recent research reports. Morgan Stanley assumed coverage on shares of Carl Zeiss Meditec in a research note on Wednesday, September 2nd. They issued an “underweight” rating for the company. Zacks Research downgraded Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 11th. Finally, UBS Group lowered Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a report on Tuesday, August 11th. Two equities research analysts have rated the stock with a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Strong Sell”.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.
The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.
See Also
- Five stocks we like better than Carl Zeiss Meditec
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
